Neurocrine Biosciences agreed to buy Soleno Therapeutics for $2.9 billion in a move intended to expand its endocrinology and rare-disease portfolio.
Source link
Neurocrine to Buy Soleno for $2.9 Billion
Date:
More like thisRelated
Inaugural New Mexico Ranch Fest kicks off
ALBUQUERQUE, N.M. (KRQE) – People got to experience a taste of...
McDonald’s to Add Energy Drinks, Crafted Sodas to Menus
A Mango Pineapple Refresher and Red Bull Dragonberry Energizer...
Christian Yelich exits Brewers’ game with hamstring tightness
Apr 12, 2026, 04:15 PM ETMILWAUKEE -- The slumping...
At least 100 dead in Nigeria after air force ‘misfire’ on market, sources say
MAIDUGURI, Nigeria -- A Nigerian Air Force strike targeting...